We examined multiple clinical parameters, such as age, sex, family history of ICAs or subarachnoid hemorrhage (SAH), serum creatinine level and the presence or absence of dialysis therapy, in addition to the serum MMP1 levels (Tables 2, S8 and S9). The gene discussed is MMP1; the disease is subarachnoid hemorrhage.